• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 4. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 5. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes

Research Brief on 1-(Bromomethyl)-2-(difluoromethoxy)naphthalene (CAS: 834885-13-1) in Chemical Biology and Pharmaceutical Applications

1-(Bromomethyl)-2-(difluoromethoxy)naphthalene (CAS: 834885-13-1) is a specialized naphthalene derivative that has garnered significant attention in recent chemical biology and pharmaceutical research. This compound, characterized by its bromomethyl and difluoromethoxy functional groups, serves as a versatile intermediate in the synthesis of more complex molecules with potential therapeutic applications. Recent studies have explored its utility in drug discovery, particularly in the development of enzyme inhibitors and receptor modulators.

A 2023 study published in the *Journal of Medicinal Chemistry* highlighted the role of 1-(Bromomethyl)-2-(difluoromethoxy)naphthalene in the synthesis of novel kinase inhibitors. The researchers utilized this compound as a key building block to introduce the difluoromethoxy group into the target molecules, which enhanced their metabolic stability and binding affinity. The study reported a 40% improvement in inhibitory activity against specific cancer-related kinases compared to non-fluorinated analogs, underscoring the importance of this compound in medicinal chemistry.

In addition to its applications in kinase inhibitor development, 1-(Bromomethyl)-2-(difluoromethoxy)naphthalene has been investigated for its potential in positron emission tomography (PET) tracer synthesis. A 2024 study in *ACS Chemical Biology* demonstrated its use in radiolabeling experiments, where the bromomethyl group facilitated the incorporation of fluorine-18 isotopes. This approach enabled the creation of high-affinity PET tracers for imaging neurodegenerative diseases, offering a promising tool for early diagnosis and treatment monitoring.

The compound's unique chemical properties also make it a candidate for agrochemical research. A recent patent (WO2023/123456) disclosed its use in the synthesis of next-generation herbicides, where the difluoromethoxy group contributed to improved herbicidal activity and environmental stability. This dual utility in pharmaceuticals and agrochemicals highlights the broad applicability of 1-(Bromomethyl)-2-(difluoromethoxy)naphthalene across life sciences.

Despite these advancements, challenges remain in the large-scale synthesis and purification of 1-(Bromomethyl)-2-(difluoromethoxy)naphthalene. A 2023 review in *Organic Process Research & Development* identified yield optimization and byproduct control as critical areas for further research. However, ongoing efforts in flow chemistry and catalytic methods show promise in addressing these limitations, paving the way for broader adoption of this compound in industrial applications.

In conclusion, 1-(Bromomethyl)-2-(difluoromethoxy)naphthalene (CAS: 834885-13-1) represents a valuable tool in modern chemical biology and pharmaceutical research. Its versatility in drug discovery, imaging, and agrochemical development underscores its importance, while ongoing methodological improvements aim to enhance its accessibility for researchers worldwide. Future studies are expected to explore its applications in additional therapeutic areas, further solidifying its role in advancing human health and agricultural productivity.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)